Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Silverstein, K. Buchanan, M. Johnston (1986)
Perinatal Hypoxia‐Ischemia Disrupts Striatal High‐Affinity [3H]Glutamate Uptake into SynaptosomesJournal of Neurochemistry, 47
Hypoxia and vascular disorders of the central nervous system
S. Rothman (1984)
Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death, 4
A. Mohamed, O. Gotoh, D. Graham, K. Osborne, J. Mcculloch, A. Mendelow, G. Teasdale, A. Harper (1985)
Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusionAnnals of Neurology, 18
O. Gotoh, A. Mohamed, J. Mcculloch, D. Graham, A. Harper, G. Teasdale (1986)
Nimodipine and the Haemodynamic and Histopathological Consequences of Middle Cerebral Artery Occlusion in the RatJournal of Cerebral Blood Flow & Metabolism, 6
B. Meldrum (1985)
Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.Clinical science, 68 2
J. Astrup (1979)
Barbiturate protection in focal cerebral ischemia.Scandinavian journal of clinical and laboratory investigation, 40 3
J. Drejer, H. Benveniste, N. Diemer, A. Schousboe (1985)
Cellular Origin of Ischemia‐Induced Glutamate Release from Brain Tissue In Vivo and In VitroJournal of Neurochemistry, 45
D. Duverger, Lars Edvinsson, E. MacKenzie, A. Oblin, L. Rouquier, Bernard Scatton, B. Ẑivković (1987)
Concentrations of Putative Neurovascular Transmitters in Major Cerebral Arteries and Small Pial Vessels of Various SpeciesJournal of Cerebral Blood Flow & Metabolism, 7
H. Hagberg, A. Lehmann, M. Sandberg, B. Nyström, I. Jacobson, A. Hamberger (1985)
Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular CompartmentsJournal of Cerebral Blood Flow & Metabolism, 5
Duverger Duverger, Benavides Benavides, Cuddennec Cuddennec (1987)
A glutamate antagonist reduces infarction size following focal cerebral ischaemia independently of vascular and metabolic changesJ Cereb Blood Flow Metab, 7
S. Rothman, J. Olney (1986)
Glutamate and the pathophysiology of hypoxic–ischemic brain damageAnnals of Neurology, 19
The effects of MK - 801 upon local cerebral glucose utilisation in conscious and in halothane - anesthetized rats
(1987)
The effects of N - methyl - D - aspanate ( NMDA ) receptor blockade upon local cerebral glucose utilisation and local cerebral blood flow
S. Rothman, J. Olney (1987)
Excitotoxity and the NMDA receptorTrends in Neurosciences, 10
E. Wong, J. Kemp, T. Priestley, A. Knight, G. Woodruff, L. Iversen (1986)
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.Proceedings of the National Academy of Sciences of the United States of America, 83 18
A. Tamura, D. Graham, J. Mcculloch, G. Teasdale (1981)
Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 1
P. Steen, J. Michenfelder (1978)
Cerebral Protection with Barbiturates Relation to Anesthetic EffectStroke, 9
E. Ozyurt, D. Graham, G. Woodruff, J. Mcculloch (1988)
Protective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the CatJournal of Cerebral Blood Flow & Metabolism, 8
M. Thiébot, J. Kloczko, R. Chermat, P. Soubrié, A. Puech, P. Simon (1982)
A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in miceDrug Development Research, 2
A. MacDermott, M. Mayer, G. Westbrook, Stephen Smith, J. Barker (1986)
NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neuronesNature, 321
A. Brown, J. Brierley (1968)
The nature, distribution and earliest stages of anoxic-ischaemic nerve cell damage in the rat brain as defined by the optical microscope.British journal of experimental pathology, 49 2
T. Shigeno, J. Mcculloch, D. Graham, A. Mendelow, G. Teasdale (1985)
Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences.Surgical neurology, 24 1
H. Benveniste, J. Drejer, A. Schousboe, N. Diemer (1984)
Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 43
I. Germano, L. Pitts, B. Meldrum, H. Bartkowski, R. Simon (1987)
Kynurenate inhibition of cell excitation decreases stroke size and deficitsAnnals of Neurology, 22
(1987)
Cuddennec A , et al : A glutamate antagonist reduces infanxion size following focal cerebral ischaemia independently of v . ~ cular and metabolic changes
B. Bose, J. Osterholm, A. Triolo (1985)
Focal cerebral ischemia: reduction in size of infarcts by ventriculo-subarachnoid perfusion with fluorocarbon emulsionBrain Research, 328
R. Simon, J. Swan, T. Griffiths, B. Meldrum (1984)
Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.Science, 226 4676
R. Gill, A. Foster, G. Woodruff (1987)
Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil, 7
J. Watkins, H. Olverman (1987)
Agonists and antagonists for excitatory amino acid receptorsTrends in Neurosciences, 10
(1986)
Selective post - ischaemic vulnerability in the brain : thrombolytic engendered hemorrhage and synaptic - induced striatal hippocampal degeneration
J. Astrup (1980)
Editorial, Part I: Barbiturate protection in focal cerebral ischemiaScandinavian Journal of Clinical & Laboratory Investigation, 40
H. Hucker, J. Hutt, S. White, B. Arison, A. Zacchei (1983)
Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys.Drug metabolism and disposition: the biological fate of chemicals, 11 1
H. Hagberg, P. Andersson, I. Kjellmer, K. Thiringer, M. Thordstein (1987)
Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemiaNeuroscience Letters, 78
Gill Gill, Foster Foster, Woodruff Woodruff (1987)
Systemic administration of MK‐801 protects against ischaemic neuropathology in ratsBr J Pharmacol, 91
Joshua Bederson, Lawrence Pitts, Miles Tsuji, M. Nishimura, Richard Davis, H. Bartkowski (1986)
Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 17 3
(1984)
R Adrenergic blockers as cerebral antiischaemic agents
B. Clineschmidt, G. Martin, P. Bunting (1982)
Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 2
Shigeno Shigeno, McCulloch McCulloch, Graham Graham (1985)
Pure cortical ischemia versus striatal ischemiaSurg Neurol, 24
K. Osborne, Anne Balarsky, McCULLOCH, G. Teasdale (1987)
Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia.Journal of Neurology, Neurosurgery & Psychiatry, 50
J. Kemp, A. Foster, E. Wong (1987)
Non-competitive antagonists of excitatory amino acid receptorsTrends in Neurosciences, 10
Clineschmidt Clineschmidt, Martin Martin, Bunting Bunting, Papp Papp (1982)
Central sympathomimetic activity of (+)‐5‐methyl‐10, ll‐dihydro‐5H‐dibenzo(a, d)cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 2
(1986)
Effects of systemic administration of the NMDA antagonist , CPP , on ischemic brain damage in gerbils
T. Bosley, P. Woodhams, R. Gordon, R. Balázs (1983)
Effects of Anoxia on the Stimulated Release of Amino Acid Neurotransmitters in the Cerebellum In VitroJournal of Neurochemistry, 40
(1961)
The imporratice of avoiding “ dark ” neurones in experimental neuropathology
Excessive activation of the N‐methyl‐D‐aspartate (NMDA) subtype of glutamate receptor has been implicated in the sequence of neurochemical events that results in irreversible neuronal damage in cerebral ischemia. The effects of the NMDA antagonist (+) ‐5‐methyl‐10,ll‐dihydro‐5H‐dibenzo(a,d)cyclohepten‐5,10‐imine maleate (MK‐801) upon the amount of ischemic brain damage has been assessed quantitatively in the lightly anesthetized rat. Focal cerebral ischemia was produced by the permanent occlusion of one middle cerebral artery (MCA), and the animals were killed 3 hours after the arterial occlusion. MK‐801 (0.5 mg/kg) was administered intravenously either 30 minutes prior to MCA occlusion or 30 minutes after the induction of ischemia. Pretreatment with MK‐801 reduced the volume of ischemic damage both in the cerebral cortex (by 38% compared with untreated rats with MCA occlusion; p < 0.01) and in the caudate nucleus (by 18% compared with controls; p < 0.05). Treatment with MK‐801, initiated 30 minutes after MCA occlusion, reduced the volume of ischemic damage in the cerebral cortex (by 52% compared with controls; p < 0.01). The volume of ischemic damage in the caudate nucleus was minimally influenced by MK‐801 treatment initiated after MCA occlusion. The antiischemic effects of MK‐801 were readily demonstrable despite the hypotension that MK‐801 induced in rats anesthetized with halothane (0.5%), nitrous oxide (70%), and oxygen (30%). The potency of MK‐801 in reducing ischemic brain damage, even when administered after the induction of ischemia, highlights the potential use of NMDA receptor antagonists for the treatment of focal cerebral ischemia in humans.
Annals of Neurology – Wiley
Published: Oct 1, 1988
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.